The global Microbial Fermentation APIs market size was valued at US$ 30680 million in 2024 and is forecast to a readjusted size of USD 33700 million by 2031 with a CAGR of 1.4% during review period.
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.
Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API"s or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).
Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).
The major players in global Microbial Fermentation APIs market include Merck, Ajinomoto, HGPF, etc. China is the main market, and occupies about 50% of the global market. Antibiotics and Amino Acids are main types, with a share over 60%.
This report is a detailed and comprehensive analysis for global Microbial Fermentation APIs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Microbial Fermentation APIs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Microbial Fermentation APIs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Microbial Fermentation APIs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Microbial Fermentation APIs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Microbial Fermentation APIs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Microbial Fermentation APIs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Ajinomoto, HGPF, Huaxing, North China Pharmaceutical, Topfond, DSM, Tianyao, CSPC Pharma, Northeast Pharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Microbial Fermentation APIs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Antibiotics
Amino Acids
Vitamin
Nucleotide
Organic Acid
Alcohol
Biological Products
Hormone
麻豆原创 segment by Application
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Major players covered
Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microbial Fermentation APIs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Microbial Fermentation APIs, with price, sales quantity, revenue, and global market share of Microbial Fermentation APIs from 2020 to 2025.
Chapter 3, the Microbial Fermentation APIs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microbial Fermentation APIs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Microbial Fermentation APIs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Microbial Fermentation APIs.
Chapter 14 and 15, to describe Microbial Fermentation APIs sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Microbial Fermentation APIs Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Antibiotics
1.3.3 Amino Acids
1.3.4 Vitamin
1.3.5 Nucleotide
1.3.6 Organic Acid
1.3.7 Alcohol
1.3.8 Biological Products
1.3.9 Hormone
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Microbial Fermentation APIs Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Research & Academic Laboratories
1.4.4 Pharmaceutical & Biotechnology Companies
1.5 Global Microbial Fermentation APIs 麻豆原创 Size & Forecast
1.5.1 Global Microbial Fermentation APIs Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Microbial Fermentation APIs Sales Quantity (2020-2031)
1.5.3 Global Microbial Fermentation APIs Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Microbial Fermentation APIs Product and Services
2.1.4 Merck Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Merck Recent Developments/Updates
2.2 Ajinomoto
2.2.1 Ajinomoto Details
2.2.2 Ajinomoto Major Business
2.2.3 Ajinomoto Microbial Fermentation APIs Product and Services
2.2.4 Ajinomoto Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Ajinomoto Recent Developments/Updates
2.3 HGPF
2.3.1 HGPF Details
2.3.2 HGPF Major Business
2.3.3 HGPF Microbial Fermentation APIs Product and Services
2.3.4 HGPF Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 HGPF Recent Developments/Updates
2.4 Huaxing
2.4.1 Huaxing Details
2.4.2 Huaxing Major Business
2.4.3 Huaxing Microbial Fermentation APIs Product and Services
2.4.4 Huaxing Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Huaxing Recent Developments/Updates
2.5 North China Pharmaceutical
2.5.1 North China Pharmaceutical Details
2.5.2 North China Pharmaceutical Major Business
2.5.3 North China Pharmaceutical Microbial Fermentation APIs Product and Services
2.5.4 North China Pharmaceutical Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 North China Pharmaceutical Recent Developments/Updates
2.6 Topfond
2.6.1 Topfond Details
2.6.2 Topfond Major Business
2.6.3 Topfond Microbial Fermentation APIs Product and Services
2.6.4 Topfond Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Topfond Recent Developments/Updates
2.7 DSM
2.7.1 DSM Details
2.7.2 DSM Major Business
2.7.3 DSM Microbial Fermentation APIs Product and Services
2.7.4 DSM Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 DSM Recent Developments/Updates
2.8 Tianyao
2.8.1 Tianyao Details
2.8.2 Tianyao Major Business
2.8.3 Tianyao Microbial Fermentation APIs Product and Services
2.8.4 Tianyao Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Tianyao Recent Developments/Updates
2.9 CSPC Pharma
2.9.1 CSPC Pharma Details
2.9.2 CSPC Pharma Major Business
2.9.3 CSPC Pharma Microbial Fermentation APIs Product and Services
2.9.4 CSPC Pharma Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 CSPC Pharma Recent Developments/Updates
2.10 Northeast Pharm
2.10.1 Northeast Pharm Details
2.10.2 Northeast Pharm Major Business
2.10.3 Northeast Pharm Microbial Fermentation APIs Product and Services
2.10.4 Northeast Pharm Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Northeast Pharm Recent Developments/Updates
2.11 Lukang Pharmaceutical
2.11.1 Lukang Pharmaceutical Details
2.11.2 Lukang Pharmaceutical Major Business
2.11.3 Lukang Pharmaceutical Microbial Fermentation APIs Product and Services
2.11.4 Lukang Pharmaceutical Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Lukang Pharmaceutical Recent Developments/Updates
2.12 Luwei Pharmaceutical
2.12.1 Luwei Pharmaceutical Details
2.12.2 Luwei Pharmaceutical Major Business
2.12.3 Luwei Pharmaceutical Microbial Fermentation APIs Product and Services
2.12.4 Luwei Pharmaceutical Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Luwei Pharmaceutical Recent Developments/Updates
2.13 Jiangshan (DSM)
2.13.1 Jiangshan (DSM) Details
2.13.2 Jiangshan (DSM) Major Business
2.13.3 Jiangshan (DSM) Microbial Fermentation APIs Product and Services
2.13.4 Jiangshan (DSM) Microbial Fermentation APIs Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Jiangshan (DSM) Recent Developments/Updates
3 Competitive Environment: Microbial Fermentation APIs by Manufacturer
3.1 Global Microbial Fermentation APIs Sales Quantity by Manufacturer (2020-2025)
3.2 Global Microbial Fermentation APIs Revenue by Manufacturer (2020-2025)
3.3 Global Microbial Fermentation APIs Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Microbial Fermentation APIs by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Microbial Fermentation APIs Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Microbial Fermentation APIs Manufacturer 麻豆原创 Share in 2024
3.5 Microbial Fermentation APIs 麻豆原创: Overall Company Footprint Analysis
3.5.1 Microbial Fermentation APIs 麻豆原创: Region Footprint
3.5.2 Microbial Fermentation APIs 麻豆原创: Company Product Type Footprint
3.5.3 Microbial Fermentation APIs 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Microbial Fermentation APIs 麻豆原创 Size by Region
4.1.1 Global Microbial Fermentation APIs Sales Quantity by Region (2020-2031)
4.1.2 Global Microbial Fermentation APIs Consumption Value by Region (2020-2031)
4.1.3 Global Microbial Fermentation APIs Average Price by Region (2020-2031)
4.2 North America Microbial Fermentation APIs Consumption Value (2020-2031)
4.3 Europe Microbial Fermentation APIs Consumption Value (2020-2031)
4.4 Asia-Pacific Microbial Fermentation APIs Consumption Value (2020-2031)
4.5 South America Microbial Fermentation APIs Consumption Value (2020-2031)
4.6 Middle East & Africa Microbial Fermentation APIs Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Microbial Fermentation APIs Sales Quantity by Type (2020-2031)
5.2 Global Microbial Fermentation APIs Consumption Value by Type (2020-2031)
5.3 Global Microbial Fermentation APIs Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Microbial Fermentation APIs Sales Quantity by Application (2020-2031)
6.2 Global Microbial Fermentation APIs Consumption Value by Application (2020-2031)
6.3 Global Microbial Fermentation APIs Average Price by Application (2020-2031)
7 North America
7.1 North America Microbial Fermentation APIs Sales Quantity by Type (2020-2031)
7.2 North America Microbial Fermentation APIs Sales Quantity by Application (2020-2031)
7.3 North America Microbial Fermentation APIs 麻豆原创 Size by Country
7.3.1 North America Microbial Fermentation APIs Sales Quantity by Country (2020-2031)
7.3.2 North America Microbial Fermentation APIs Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Microbial Fermentation APIs Sales Quantity by Type (2020-2031)
8.2 Europe Microbial Fermentation APIs Sales Quantity by Application (2020-2031)
8.3 Europe Microbial Fermentation APIs 麻豆原创 Size by Country
8.3.1 Europe Microbial Fermentation APIs Sales Quantity by Country (2020-2031)
8.3.2 Europe Microbial Fermentation APIs Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Microbial Fermentation APIs Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Microbial Fermentation APIs Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Microbial Fermentation APIs 麻豆原创 Size by Region
9.3.1 Asia-Pacific Microbial Fermentation APIs Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Microbial Fermentation APIs Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Microbial Fermentation APIs Sales Quantity by Type (2020-2031)
10.2 South America Microbial Fermentation APIs Sales Quantity by Application (2020-2031)
10.3 South America Microbial Fermentation APIs 麻豆原创 Size by Country
10.3.1 South America Microbial Fermentation APIs Sales Quantity by Country (2020-2031)
10.3.2 South America Microbial Fermentation APIs Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Microbial Fermentation APIs Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Microbial Fermentation APIs Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Microbial Fermentation APIs 麻豆原创 Size by Country
11.3.1 Middle East & Africa Microbial Fermentation APIs Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Microbial Fermentation APIs Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Microbial Fermentation APIs 麻豆原创 Drivers
12.2 Microbial Fermentation APIs 麻豆原创 Restraints
12.3 Microbial Fermentation APIs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Microbial Fermentation APIs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Microbial Fermentation APIs
13.3 Microbial Fermentation APIs Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Microbial Fermentation APIs Typical Distributors
14.3 Microbial Fermentation APIs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
听
听
*If Applicable.
